The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

nlmixr2save: Save 'nlmixr2' Fits in a Format Readable Outside 'nlmixr2'

Provides tools to save 'nlmixr2' fitted models in a portable format readable outside of 'nlmixr2' and independent of the package version. 'nlmixr2' fits and compares nonlinear mixed-effects models in differential equations with flexible dosing information commonly seen in pharmacokinetics and pharmacodynamics (Almquist, Leander, and Jirstrand 2015 <doi:10.1007/s10928-015-9409-1>). Differential equation solving uses compiled C code from the 'rxode2' package (Wang, Hallow, and James 2015 <doi:10.1002/psp4.12052>).

Version: 0.1.0
Imports: checkmate, cli, digest, Rcpp, rxode2 (> 5.0.1), zip
LinkingTo: Rcpp
Suggests: babelmixr2, dplyr, knitr, nlmixr2data, nlmixr2est (≥ 5.0.2), PopED, rmarkdown, testthat (≥ 3.0.0), tidyvpc, withr
Published: 2026-06-17
DOI: 10.32614/CRAN.package.nlmixr2save
Author: Matthew Fidler ORCID iD [aut, cre]
Maintainer: Matthew Fidler <matthew.fidler at gmail.com>
License: MIT + file LICENSE
NeedsCompilation: yes
Materials: README, NEWS
CRAN checks: nlmixr2save results

Documentation:

Reference manual: nlmixr2save.html , nlmixr2save.pdf
Vignettes: Registering simulation functions (source, R code)
Using nlmixr2save (source, R code)

Downloads:

Package source: nlmixr2save_0.1.0.tar.gz
Windows binaries: r-devel: nlmixr2save_0.1.0.zip, r-release: nlmixr2save_0.1.0.zip, r-oldrel: nlmixr2save_0.1.0.zip
macOS binaries: r-release (arm64): nlmixr2save_0.1.0.tgz, r-oldrel (arm64): nlmixr2save_0.1.0.tgz, r-release (x86_64): nlmixr2save_0.1.0.tgz, r-oldrel (x86_64): nlmixr2save_0.1.0.tgz

Linking:

Please use the canonical form https://CRAN.R-project.org/package=nlmixr2save to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.